Thomas M Blok

Thomas M Blok
Thomas M Blok

Assistant Professor, Department of Medicine


Biosketch

  • Board Certification

    • American Board of Internal Medicine (Internal Medicine)
  • Education and Training

    • Residency 1986, Internal Medicine, Southwest Michigan Area Health Education Center
    • MD 1983, University of Michigan-Ann Arbor
    • BA 1979, Kalamazoo College
  • Research

    • Internal Medicine
  • Publications

    • Schwartz G.G., Szarek M., Bittner V.A., Diaz R., Goodman S.G., Jukema J.W., Landmesser U., López-Jaramillo P., Manvelian G., Pordy R., Scemama M., Sinnaeve P.R., White H.D., Gabriel Steg P.H., Bhatt D.L., Harrington R.A., Zeiher A.M., Tricoci P., Roe M.T., Mahaffey K.W., Edelberg J.M., Hanotin C., Lecorps G., Moryusef A., Sasiela W.J., Tamby J.F., Aylward P.E., Drexel H., Sinnaeve P., Dilic M., Lopes R.D., Gotcheva N.N., Prieto J.C., Yong H., Pećin I., Reiner Z., Ostadal P., Poulsen S.H., Viigimaa M., Nieminen M.S., Danchin N., Chumburidze V., Marx N., Liberopoulos E., Montenegro Valdovinos P.C., Tse H.F., Kiss R.G., Xavier D., Zahger D., Valgimigli M., Kimura T., Kim H.S., Kim S.H., Erglis A., Laucevicius A., Kedev S., Yusoff K., Ramos López G.A., Alings M., Halvorsen S., Correa Flores R.M., Sy R.G., Budaj A., Morais J., Dorobantu M., Karpov Y., Ristic A.D., Chua T., Murin J., Fras Z., Dalby A.J., Tuñón J., Asita de Silva H., Hagström E., Müller C., Chiang C.E., Sritara P., Guneri S., Parkhomenko A., Ray K.K., Moriarty P.M., Vogel R., Chaitman B., Kelsey S.F., Olsson A.G., Rouleau J.L., Simoons M.L., Alexander K., Meloni C., Rosenson R., Sijbrands E.J.G., Alexander J.H., Armaganijan L., Bagai A., Bahit M.C., Brennan J.M., Clifton S., DeVore A.D., Deloatch S. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol Journal of the American College of Cardiology. 2021;78:421-433.

    • Beam C.A., Wasserfall C., Woodwyk A., Akers M.K., Rauch H., Blok T., Mason P., Vos D., Perry D., Brusko T., Peakman M., Atkinson M. Synchronization of the Normal Human Peripheral Immune System: A Comprehensive Circadian Systems Immunology Analysis Scientific Reports. 2020;10

    • Ray K.K., Colhoun H.M., Szarek M., Baccara-Dinet M., Bhatt D.L., Bittner V.A., Budaj A.J., Diaz R., Hanotin C., Harrington R.A., Jukema J.W., Loizeau V., Lopes R.D., Moryusef A., Murin J., Pordy R., Ristic A.D., Roe M.T., Tuñón J., White H.D., Zeiher A.M., Schwartz G.G., Steg P.G., Goodman S.G., Tricoci P., Mahaffey K.W., Edelberg J.M., Lecorps G., Sasiela W.J., Tamby J.F., Aylward P.E., Drexel H., Sinnaeve P., Dilic M., Gotcheva N.N., Prieto J.C., Yong H., López-Jaramillo P., Pećin I., Reiner Z., Ostadal P., Viigimaa M., Nieminen M.S., Chumburidze V., Marx N., Danchin N., Liberopoulos E., Montenegro Valdovinos P.C., Tse H.F., Kiss R.G., Xavier D., Zahger D., Kimura T., Kim H.S., Valgimigli M., Kim S.H., Erglis A., Laucevicius A., Kedev S., Yusoff K., Ramos López G.A., Alings M., Halvorsen S., Correa Flores R.M., Morais J., Dorobantu M., Karpov Y., Chua T., Fras Z., Dalby A.J., de Silva H.A., Hagström E., Landmesser U., Chiang C.E., Sritara P., Guneri S., Parkhomenko A., Moriarty P.M., Vogel R., Chaitman B., Kelsey S.F., Olsson A.G., Rouleau J.L., Simoons M.L., Alexander K., Meloni C., Rosenson R. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial The Lancet Diabetes and Endocrinology. 2019;7:618-628.

    • Schwartz G.G., Steg P.G., Szarek M., Bhatt D.L., Bittner V.A., Diaz R., Edelberg J.M., Goodman S.G., Hanotin C., Harrington R.A., Jukema J.W., Lecorps G., Mahaffey K.W., Moryusef A., Pordy R., Quintero K., Roe M.T., Sasiela W.J., Tamby J.F., Tricoci P., White H.D., Zeiher A.M., Aylward P.E., Drexel H., Sinnaeve P., Dilic M., Lopes R.D., Gotcheva N.N., Prieto J.C., Yong H., Lopez-Jaramillo P., Pecin I., Reiner Z., Ostadal P., Poulsen S.H., Viigimaa M., Nieminen M.S., Danchin N., Chumburidze V., Marx N., Liberopoulos E., Valdovinos P.C.M., Tse H.F., Kiss R.G., Xavier D., Zahger D., Valgimigli M., Kimura T., Kim H.S., Kim S.H., Erglis A., Laucevicius A., Kedev S., Yusoff K., Ramos Lopez G.A., Alings M., Halvorsen S., Correa Flores R.M., Sy R.G., Budaj A., Morais J., Dorobantu M., Karpov Y., Ristic A.D., Chua T., Murin J., Fras Z., Dalby A.J., Tunon J., de Silva H.A., Hagstrom E., Muller C., Chiang C.E., Sritara P., Guneri S., Parkhomenko A., Ray K.K., Moriarty P.M., Vogel R., Chaitman B., Kelsey S.F., Olsson A.G., Rouleau J.L., Simoons M.L., Alexander K., Meloni C., Rosenson R., Sijbrands E.J.G., Alexander J.H., Armaganijan L., Bagai A., Bahit M.C., Brennan J.M., Clifton S., Devore A.D., Deloatch S., Dickey S., Dombrowski K., Ducrocq G., Eapen Z. Alirocumab and cardiovascular outcomes after acute coronary syndrome New England Journal of Medicine. 2018;379:2097-2107.

    • Beigel J.H., Tebas P., Elie-Turenne M.C., Bajwa E., Bell T.E., Cairns C.B., Shoham S., Deville J.G., Feucht E., Feinberg J., Luke T., Raviprakash K., Danko J., O'Neil D., Metcalf J.A., King K., Burgess T.H., Aga E., Lane H.C., Hughes M.D., Davey R.T., Quinn J., Jiang Y., Elie-Turenne M., Hoelle R., Iovine N., Wills R.S., Pata S., Huggins M., Manukian B., Holland C., Brait K., Hunt T., Stowell C., Slater A., Bell T., Townsends M., Cairns C., Quackenbush E.B., Park Y.A., Jordan P.G., Blanchet C., Chronowski K., Alvarez K., Ostrander D., Woessner T., Thoman S., Deville J., Lin J., Ziman A., Shankar K., Blok T., Batts D., Beck B., Massey G., Bradley C., Carey P., Baer J., Whitehead E.M., Kohrs S., Giulitto R., Schofield C., Fairchok M., Chambers S., Baker C., RN , Parker M., Harshbarger M., Nguyen M., Carey M.E., Paronish J., Cornell F., Cramer J., Pakstis D.L., Ison M.G., Wunderink R., Glesby M., Ham K., Hughes V., Cushing M., Goss C., Grenade J., Park P.K., Napolitano L.M., Raghavendran K., Hyzy R.C., Davenport R., Brierley K., Downs T., Gong M.N., Uehlinger J., Lin M., Fritsche J., Green T., McLeod B. Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study The Lancet Respiratory Medicine. 2017;5(6):500-511.

    • Henderson L.W., Dittrich H.C., Strickland A., Blok T.M., Newman R., Oliphant T., Albrecht D. A Phase 1 dose-ranging study examining the effects of a superabsorbent polymer (CLP) on fluid, sodium and potassium excretion in healthy subjects BMC Pharmacology and Toxicology. 2014;15(1)

    • Kaufman K.D., Erb D.J., Blok T.M., Carlson R.W., Knoechel D., Mcbride L., Zeitlow T. Reactions of furocoumarins. II. Synthetic aminomethyl psoralens via chloromethylation or benzylic bromination Journal of Heterocyclic Chemistry. 1982;19:1051-1056.